SCHEMBL4158399

SCHEMBL4158399

CCOP(=O)(CCCO)OCC

nearest known ligand 0.74

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 2/20 0.74
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4456025 0.93 PPARD (0.71) PPARDTSHRTP53TDP1
SCHEMBL2405777 0.92 PPARD (0.63) PPARDTSHRTP53TDP1CA12
SCHEMBL9889143 0.91 PPARD (0.68) PPARDTSHR
SCHEMBL7451944 0.91 PPARD (0.68) PPARDTSHR
SCHEMBL577996 0.91 PPARD (0.68) PPARDTSHR
SCHEMBL18590889 0.91 PPARD (0.68) PPARDTSHR
SCHEMBL30956301 0.91 PPARD (0.68) PPARDTSHR
SCHEMBL993811 0.85 PPARD (1.00) PPARDTSHRTP53TDP1CA12
SCHEMBL7268189 0.85 PPARD (0.64) PPARDTSHRTP53TDP1
SCHEMBL5017294 0.85 PPARD (0.64) PPARDTSHRTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12611843-B2 Flame lamination additive for polyurethane foam ICL-IP AMERICA INC. (US) 2026-04-28 US claimed
US-20240300210-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL IP AMERICA INC (US) 2024-09-12 US claimed
EP-4291592-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL-IP America Inc. (US) 2023-12-20 EP claimed
WO-2022173532-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL-IP AMERICA INC. (US) 2022-08-18 WO claimed
US-20180327671-A1 FLAME RETARDANT LIQUID SOLUTION, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM ICL-IP AMERICA INC. 2018-11-15 US claimed
US-12611843-B2 Flame lamination additive for polyurethane foam ICL-IP AMERICA INC. (US) 2026-04-28 US disclosed
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
US-20240300210-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL IP AMERICA INC (US) 2024-09-12 US disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
EP-4291592-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL-IP America Inc. (US) 2023-12-20 EP disclosed
WO-2022173532-A1 FLAME LAMINATION ADDITIVE FOR POLYURETHANE FOAM ICL-IP AMERICA INC. (US) 2022-08-18 WO disclosed
WO-1988005438-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1988-07-28 WO disclosed
EP-0274025-A2 Novel antiviral agents SRI INTERNATIONAL (US) 1988-07-13 EP disclosed
EP-0273169-A2 Novel antiviral agents SRI INTERNATIONAL (US) 1988-07-06 EP disclosed
EP-0272446-A1 Novel antiviral agents SRI INTERNATIONAL (US) 1988-06-29 EP disclosed
WO-1984004748-A2 NOVEL ANTIVIRAL AGENTS 1984-12-06 WO disclosed
US-4048374-A Functional organophosphonic acid esters as preservative adhesion promoting agents and coating for metals DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-09-13 US disclosed
US-4029679-A PROTECTIVE METAL COATING DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1977-06-14 US disclosed
US-4022757-A Dicarbamic acid diesters containing phosphorus BAYER AKTIENGESELLSCHAFT (DT) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS BCL2, BCL2A1, BAX PPARD 2334/4885TSHR 3129/4885TP53 800/4885
US-12611843-B2 Flame lamination additive for polyurethane foam FGB, PFAS, FLNB PPARD 2783/4885TSHR 4435/4885TP53 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.